A Study to Examine the Tolerability, Safety and Pharmacokinetics of Single Oral Doses of RGH-618 in Healthy Male Volunteers

Trial Profile

A Study to Examine the Tolerability, Safety and Pharmacokinetics of Single Oral Doses of RGH-618 in Healthy Male Volunteers

Planning
Phase of Trial: Phase I

Latest Information Update: 20 Apr 2016

At a glance

  • Drugs RGH 618 (Primary)
  • Indications Anxiety; Anxiety disorders
  • Focus Adverse reactions; First in man
  • Sponsors Gedeon Richter
  • Most Recent Events

    • 20 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top